# Comparative Study of EnliTuo® Before and After Technology Change in Healthy Male Volunteers

> **NCT07246291** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Taizhou Mabtech Pharmaceutical Co.,Ltd** · enrollment: 86 (estimated)

## Conditions studied

- Healthy Adult Male

## Interventions

- **BIOLOGICAL:** New technology Enlituo
- **BIOLOGICAL:** Approved technology Enlituo

## Key facts

- **NCT ID:** NCT07246291
- **Lead sponsor:** Taizhou Mabtech Pharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-11
- **Primary completion:** 2026-04-16
- **Final completion:** 2026-05-13
- **Target enrollment:** 86 (ESTIMATED)
- **Last updated:** 2026-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07246291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07246291, "Comparative Study of EnliTuo® Before and After Technology Change in Healthy Male Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07246291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*